Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) President Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $15.99, for a total value of $479,700.00. Following the completion of the sale, the president now owns 2,417,700 shares of the company’s stock, valued at $38,659,023. This represents a 1.23 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Dawn Christine Maroney also recently made the following trade(s):
- On Wednesday, March 12th, Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.43, for a total value of $420,359.49.
- On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total value of $4,331,581.01.
- On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.72, for a total value of $411,600.00.
- On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.61, for a total value of $408,300.00.
Alignment Healthcare Trading Up 1.9 %
NASDAQ ALHC opened at $16.09 on Tuesday. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. Alignment Healthcare, Inc. has a twelve month low of $4.46 and a twelve month high of $16.26. The company has a market cap of $3.09 billion, a price-to-earnings ratio of -20.90 and a beta of 1.49. The business’s fifty day moving average is $14.48 and its 200 day moving average is $12.51.
Institutional Investors Weigh In On Alignment Healthcare
Wall Street Analysts Forecast Growth
Several research analysts recently commented on ALHC shares. JPMorgan Chase & Co. increased their price target on Alignment Healthcare from $14.00 to $17.00 and gave the company a “neutral” rating in a research report on Thursday, March 6th. Bank of America upped their price objective on Alignment Healthcare from $15.50 to $18.50 and gave the company a “buy” rating in a research note on Tuesday, March 4th. William Blair reiterated an “outperform” rating on shares of Alignment Healthcare in a research note on Friday, February 28th. Stifel Nicolaus increased their target price on Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a research note on Friday, February 28th. Finally, Piper Sandler raised their price objective on Alignment Healthcare from $14.00 to $21.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 4th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $14.83.
View Our Latest Stock Analysis on ALHC
Alignment Healthcare Company Profile
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Further Reading
- Five stocks we like better than Alignment Healthcare
- What is the Australian Securities Exchange (ASX)
- Can TikTok Stock Picks Really Make You Rich?
- How to Short Nasdaq: An Easy-to-Follow Guide
- The “Quality” Rotation: Back to Basics Investing
- How to Find Undervalued Stocks
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.